Minerva Neurosciences, Inc.
NERV · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $21 | $41 | $36 | $61 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $4 | $1 |
| Total Curr. Assets | $22 | $42 | $40 | $62 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $15 | $15 | $15 | $15 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $15 | $15 | $15 | $15 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $37 | $57 | $55 | $77 |
| Liabilities | – | – | – | – |
| Payables | $2 | $2 | $1 | $2 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $2 | $0 | $1 |
| Total Curr. Liab. | $3 | $3 | $1 | $3 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $60 | $82 | $74 | $66 |
| Total NC Liab. | $60 | $82 | $74 | $66 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $63 | $85 | $75 | $69 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$395 | -$397 | -$367 | -$335 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $370 | $368 | $347 | $343 |
| Total Equity | -$26 | -$28 | -$20 | $8 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $37 | $57 | $55 | $77 |
| Net Debt | -$21 | -$41 | -$36 | -$61 |